AC

ACELYRIN, Inc.

  • CIK: 0001962918
  • EIN: 85-2406735
  • Business address: 4149 LIBERTY CANYON RD., AGOURA HILLS, California, 91301

Information

  • Mailing address
    4149 LIBERTY CANYON RD., AGOURA HILLS, Delaware, 91301
  • Phone
    805-871-4300
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About ACELYRIN, Inc.

ACELYRIN, Inc. (CIK: 0001962918) is an American company incorporated in the state of California. Head office is located at 4149 LIBERTY CANYON RD., AGOURA HILLS, California, 91301. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. ACELYRIN, Inc. is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
Labrucherie Gil M 0001394875 Aug-02-2023 officer: Interim CFO
SEIDENBERG BETH C 0001184592 May-04-2023 director, 10 percent owner
COZADD BRUCE C 0001193210 May-04-2023 director
Machado Patrick 0001311210 May-04-2023 director
Colowick Alan 0001316163 May-04-2023 director
Harper Sean E 0001541946 May-04-2023 10 percent owner
GOEL DAVID E. 0001548144 May-04-2023 director, 10 percent owner, other: See Remarks
Svoronos Dawn 0001574579 May-04-2023 director
Dier Mardi 0001574591 May-04-2023 officer: CFO and CBO
Gosebruch Henry O 0001659625 May-04-2023 director
Kim Mina 0001668163 May-04-2023 officer: Chief Legal & Admin. Officer
Lin Shao-Lee 0001725092 May-04-2023 director, officer: Chief Executive Officer
Becker Daniel J. 0001752139 May-04-2023 director
Westlake BioPartners Fund II, L.P. 0001811947 May-04-2023 10 percent owner
Westlake BioPartners GP II, LLC 0001811948 May-04-2023 10 percent owner
Gloria Melanie 0001973838 May-04-2023 officer: Chief Operating Officer
Peloso Paul 0001973848 May-04-2023 officer: Chief Medical Officer
Oyston Ronald 0001973851 May-04-2023 officer: Chief People Officer
AyurMaya Capital Management Company, LP 0001975990 May-04-2023 director, 10 percent owner, other: See Remarks

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ACELYRIN, Inc.

Filings Format Description Filed/Effective File/Film Number
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0001104659-25-057733 (34 Act) Size: KB		 Jun-09-2025

001-41696

251033512
SCHEDULE 13D/A Document Acc-no: 0001963860-25-000019 (34 Act) Size: KB May-27-2025

005-94068

25984623
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000902664-25-002533 ( Act) Size: 0 KB		 May-23-2025

SCHEDULE 13D/A Document Acc-no: 0001214659-25-008304 (34 Act) Size: KB May-23-2025

005-94068

25982462
SCHEDULE 13G/A Document Acc-no: 0000902664-25-002530 (34 Act) Size: KB May-23-2025

005-94068

25982425
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000068 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000066 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000064 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000062 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000060 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000058 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000056 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000054 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000052 ( Act) Size: 0 KB		 May-23-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001962918-25-000050 ( Act) Size: 0 KB		 May-23-2025

SCHEDULE 13D/A Document Acc-no: 0000950170-25-076892 (34 Act) Size: KB May-23-2025

005-94068

25981971
EFFECT Document Acc-no: 9999999995-25-001700 (33 Act) Size: KB May-22-2025

333-283209

25979085
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-25-051723 (33 Act) Size: KB		 May-22-2025

333-285915

25974459
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-25-051722 (33 Act) Size: KB		 May-22-2025

333-278333

25974457
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-25-051721 (33 Act) Size: KB		 May-22-2025

333-271737

25974454

Recent 20 filings. View all ACELYRIN, Inc. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Frequently Asked Questions

Tags:

  • ACELYRIN, Inc. overview
  • ACELYRIN, Inc. job
  • ACELYRIN, Inc. stock
  • ACELYRIN, Inc. ownership
  • ACELYRIN, Inc. CEO
  • ACELYRIN, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

atai Life Sciences Luxembourg S.A.
Update: Sep 23, 2025
Hyperliquid Strategies Inc
Update: Sep 05, 2025
Polaryx Therapeutics, Inc.
Update: Sep 05, 2025
Nasus Pharma Ltd
Update: Jul 10, 2025
Promicell, Inc.
Update: May 30, 2025
Maius Pharmaceutical Group Co., Ltd.
Update: Mar 01, 2025

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1092 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3791 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4953 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4066 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1541 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1420 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1965 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1850 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3115 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by